This story originally ran on Oct. 7 and has been updated to include comments from a Ludesi official.
Swedish bioinformatics firm Ludesi filed for bankruptcy last month, ending availability of the company's 2D gel image analysis service Redfin.
Ludesi had offered the Redfin platform through a partnership agreement with Bio-Rad that the companies announced in May. The service used a downloadable software interface to let researchers upload their 2D gel images for analysis by a team of Redfin gel analyzers.
Bio-Rad treasurer Ron Hutton told ProteoMonitor the company is "aware that [Redfin] is not available" and is in the process of "making sure that our customers are covered one way or another." He mentioned the company's PDQuest gel analysis software as a possible alternative.
In an email to ProteoMonitor, Ludesi CEO Ola Forsstrom-Olsson said that "the Redfin software is still running, and there are Redfin users who use it to analyze their 2D gel images." He did not clarify, however, whether the Redfin service was still available for sale and fully-supported. Two of Ludesi's European distributors, Reactionlab and Diax, also told ProteoMonitor they no longer offered Redfin.
Launched in 2001, in 2006 Ludesi received $3.4 million in funding from private equity firm InnovationsKapital, which is the company's largest shareholder (GWDN 09/21/2006). It also counts the Sixth AP Fund as an investor.